Benchmark reissued their buy rating on shares of IMAX (NYSE:IMAX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. Benchmark currently has a $22.00 price objective on the stock. Other equities research analysts have also issued reports about the company. The Goldman Sachs Group dropped their price target on […]